newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals Appoints James Huang to Board of Directors

- Industry veteran brings over 35 years of biotech experience as a successful entrepreneur and investor- Operating experience to significantly enhance development program of CID-103